Abstract
In this study, we investigated the roles of active efflux pumps in antibiotic resistance. The transcription efflux pump genes were analyzed by real-time polymerase chain reaction (qPCR) to determine their role in drug resistance. Antibiotic sensitivity testing was carried out using the Vitek 2 automated system (bioMérieux, France). Isolates were divided into four groups according to their resistance status: multiple-drug resistant (MDR), isolated carbapenem resistant (ICR), isolated quinolone resistant (IQR), and carbapenem and quinolone resistant (CQR). Transcript levels of mexB, mexD, mexF, and mexY were analyzed by qPCR using a LightCycler instrument (Roche, Germany). The genetic similarity between isolates was determined using arbitrarily primed PCR (AP-PCR). Among the 50 isolates investigated, the frequency of genes classified as overexpressed were 88 % for mexD, 76 % for mexB, 46 % for mexF, and 40 % for mexY. Within the MDR group, mexB was overexpressed in 15 of 22 isolates, mexD in 20 of 22, mexF in 15 of 22, and mexY in 19 of 22. In the ICR group, isolates mexB and mexD were each overexpressed in five isolates. mexD overexpression was observed in all seven CQR isolates. Within the IQR group, mexB and mexD were overexpressed in all 12 isolates. mexF overexpression was detected in 7 of 12 isolates in this group. 18 distinct banding patterns were determined by AP-PCR. Increased transcription of mexB was directly correlated with meropenem resistance in the majority of isolates tested, while MexCD-OprJ and MexEF-OprN were related to quinolone resistance; the MexCD-OprJ efflux pump was also related to multidrug resistance. Increased transcription of mexY may contribute to the gentamicin resistance.
Similar content being viewed by others
References
Bonfiglio G, Russo G, Nicoletti G (2002) Recent developments in carbapenems. Expert Opin Investig Drugs 11(4):529–544
Cabot G, Ocampo-Sosa AA, Tubau F, Macia MD, Rodriguez C, Moya B, Zamorano L, Suarez C, Pena C, Martinez-Martinez L, Oliver A, the Spanish Network for Research in Infectious Diseases (REIPI) (2011) Overexpression of AmpC and efflux pumps in Pseudomonas aeruginosa ısolates from bloodstream ınfections: prevalence and ımpact on resistance in a Spanish Multicenter Study. Antimicrob Agents Chemother 55(5):1906–1911
El Amin N, Giske CG, Jalal S, Keijser B, Kronvall G, Wretlind B (2005) Carbapenem resistance mechanisms in Pseudomonas aeruginosa: alterations of porin OprD and efflux proteins do not fully explain resistance patterns observe in clinical isolates. APMIS 113(3):187–196
Giske CG, Buaro L, Sundsfjord A, Wretlind B (2008) Alterations of porin, pumps, and penicillin-binding proteins in carbapenem resistant clinical ısolates of Pseudomonas aeruginosa. Microb Drug Resist 14(1):23–30
Henrichfreise B, Wiegand I, Pfister W, Wiedemann B (2007) Resistance mechanisms of multiresistant Pseudomonas aeruginosa strains from Germany and correlation with hypermutation. Antimicrob Agents Chemother 51(11):4062–4070
Hocquet D, Nordmann P, El Garch F, Cabanne L, Plesiat P (2006) Involvement of the MexXY–OprM efflux system in emergence of cefepime resistance in clinical strains of Pseudomonas aeruginosa. Antimicrob Agents Chemother 50(4):1347–1351
Islam S, Jalal S, Wretlind B (2004) Expression of the MexXY efflux pump in amikacin-resistant isolates of Pseudomonas aeruginosa. Clin Microbiol Infect 10(10):877–883
Kohler T, Kok M, Michea-Hamzehpour M, Plesiat P, Gotoh N, Nishino T, Curty LK, Pechere JC (1996) Multidrug efflux in intrinsic resistance to trimethoprim and sulfamethoxazole in Pseudomonas aeruginosa. Antimicrob Agents Chemother 40(10):2288–2290
Kohler T, Michea-Hamzehpour M, Henz U, Gotoh N, Curty LK, Pechere JC (1997) Characterization of MexE–MexF–OprN, a positively regulated multidrug efflux system of Pseudomonas aeruginosa. Mol Microbiol 23(2):345–354
Li XZ, Nikaido H, Poole K (1995) Role of mexA–mexB–oprM in antibiotic efflux in Pseudomonas aeruginosa. Antimicrob Agents Chemother 39(9):1948–1953
Li XZ, Zhang L, Srikumar R, Poole K (1998) Beta-lactamase inhibitors are substrates for the multidrug efflux pumps of Pseudomonas aeruginosa. Antimicrob Agents Chemother 42(2):399–403
Lister PD, Wolter DJ, Hanson ND (2009) Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms. Clin Microbiol Rev 22(4):582–610
McGowan JE Jr (2006) Resistance in nonfermenting gram negative bacteria: multidrug resistance to the maximum. Am J Infect Control 34(5 Suppl 1):29–37
Morita Y, Murata T, Mima T, Shiota S, Kuroda T, Mizushima T, Gotoh N, Nishino T, Tsuchiya T (2003) Induction of mexCD-oprJ operon for a multidrug efflux pump by disinfectants in wild-type Pseudomonas aeruginosa PAO1. J Antimicrob Chemother 51(4):991–994
Nikaido H, Pages JM (2012) Broad-specificity efflux pumps and their role in multi drug resistance of Gram-negative bacteria. FEMS Microbiol Rev 36(2):340–363
Oh H, Stenhoff J, Jalal S, Wretlind B (2003) Role of efflux pumps and mutations in genes for topoisomerases II and IV in fluoroquinolone-resistant Pseudomonas aeruginosa strains. Microb Drug Resist 9(4):323–328
Pechere JC, Kohler T (1999) Patterns and modes of beta-lactam resistance in Pseudomonas aeruginosa. Clin Microbiol Infect 5(Suppl 1):15–18
Pfaffl MW, Tichopad A, Prgomet C, Neuvians TP (2004) Determination of stable housekeeping genes, differentially regulated target genes and sample integrity: BestKeeper—Excel-based tool using pair-wise correlations. Biotechnol Lett 26(6):509–515
Poole K (2002) Outer membranes and efflux: the path to multidrug resistance in Gram-negative bacteria. Curr Pharm Biotechnol 3(2):77–98
Poole K (2012) Efflux-mediated antimicrobial resistance. In: Dougherty TJ, Pucci MJ (eds) Antibiotic discovery and development, vol 1. Springer, New York, pp 349–395
Poole K, Srikumar R (2001) Multidrug efflux in Pseudomonas aeruginosa: components, mechanisms and clinical significance. Curr Top Med Chem 1(1):59–71
Poole K, Gotoh N, Tsujimoto H, Zhao Q, Wada A, Yamasaki T, Neshat S, Yamagishi J, Li XZ, Nishino T (1996) Overexpression of the mexC–mexD–oprJ efflux operon in nfxB-type multidrug resistant strains of Pseudomonas aeruginosa. Mol Microbiol 21(4):713–724
Schweizer HP (2003) Efflux as a mechanism of resistance to antimicrobials in Pseudomonas aeruginosa and related bacteria: unanswered questions. Genet Mol Res 2(1):48–62
Shiba T, Ishiguro K, Takemoto N, Koibuchi H, Sugimoto K (1995) Purification and characterization of the Pseudomonas aeruginosa NfxB protein, the negative regulator of the nfxB gene. J Bacteriol 177(20):5872–5877
Strateva T, Yordanov D (2009) Pseudomonas aeruginosa—a phenomenon of bacterial resistance. J Med Microbiol 58(Pt 9):1133–1148
Xavier DE, Picao RC, Girardello R, Fehlberg LC, Gales AC (2010) Efflux pumps expression and its association with porin down-regulation and β-lactamase production among Pseudomonas aeruginosa causing bloodstream infections in Brazil. BMC Microbiol 10:217
Acknowledgments
This study was granted approval by the local Ethics in Research Committee.
Conflict of interest
None declared.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Terzi, H.A., Kulah, C. & Ciftci, İ.H. The effects of active efflux pumps on antibiotic resistance in Pseudomonas aeruginosa . World J Microbiol Biotechnol 30, 2681–2687 (2014). https://doi.org/10.1007/s11274-014-1692-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11274-014-1692-2